![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 11, 2020 10:10:56 AM
First, we all know NWBO doesn't make timelines and that employees of the company frequently make misleading statements. But, to a large degree, that is why we are all here in the first place. At $.16/share NWBO was incredibly undervalued if you believed the published clinical data. It's a little bit of a chicken/egg thing as to whether the company's inability to do what/when it says led to the short-seller attack or vice-versa, but regardless, that is how we got to NWBO having a fully-diluted market cap below $300m while advancing a late Phase III trial with very good blinded data in a multi-billion dollar application.
Despite the years and years of history (I lost a lot of money on NWBO 5+ years ago) I believe the risk/reward for NWBO is very, very favorable and when the stock was trading sub $.20 I'd expand my position 1-2% every week to the point that eventually NWBO accounted for more than 2/3 of my stock portfolio (maybe 20% of my net worth).
When NWBO hit $.75 - $1.20 I started selling and sold almost 20% of my position, recovering my entire cost basis for NWBO. I sold because I was massively overweighted in NWBO and the risk/reward had changed incrementally. Note: After all this appreciation, NWBO is now 80% of my portfolio and more than 50% of my net worth.
One thing people haven't mentioned on this board which is the primary reason for my post is this. We need to think in terms of marginal utility. If NWBO goes to $8, how much money will you make? What is the incremental benefit to you if it goes to $9? For me, the incremental utility of the $1 gain in NWBO stock price from $8 to $9 is not that high while the incremental utility on what NWBO stock has achieved so far is very high.
So, if you have a large (relative to your financial situation) position in NWBO, yes, you should absolutely take some chips off the table. If it's a small portion of your net worth, then don't worry about it and swing for the fences. There are exceptions like tryn who is trying to change the arc if his retirement. That makes sense.
So, to conclude, GGB, you've been watching NWBO for many years. You follow this message board and have developed a level of trust in some of the experts who post here. You know what NWBO is and is not. You know what can be known about DCVax-L and Direct. Presumably, you understand your financial situation and have performed the type of analysis I suggest above. If yes, then you should disengage to some extent. Turn off your computer and read a book or fly a kite. Try not to think about NWBO. Try not to let your emotions overcome your judgement and your years of due diligence.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM